Jordan C T, Astle C M, Zawadzki J, Mackarehtschian K, Lemischka I R, Harrison D E
Department of Molecular Biology, Princeton University, NJ, USA.
Exp Hematol. 1995 Aug;23(9):1011-5.
To characterize hematopoietic cell biology, many investigators have used protocols that enrich for primitive hematopoietic stem cells (PHSC). In this study, we quantified the long-term repopulating ability (LTRA) of enriched and discarded fractions of PHSC from day-14 murine fetal liver using the competitive repopulation assay. We fractionated populations of fetal cells using the antigenic markers AA4.1+, AA4.1+/Sca+, and AA4.1+/Linlow/Sca+. Differentiating and repopulating abilities of each of these populations were directly compared using competitive repopulation. Adult bone marrow was mixed with fetal cell fractions from congenic donors having genetically distinguishable markers, and mixtures were given to irradiated recipients. Differentiating and repopulating abilities of the enriched donor cells were measured by the proportions of myeloid and lymphoid cells having donor markers that repopulated the recipients. LTRA was found primarily in the AA4.1+ and AA4.1+/Sca+ subpopulations. Further fractionation of the AA4.1+ cells to derive an AA4.1+/Linlow/Sca+ fraction showed that virtually all of the long-term stem cell activity was found in this subpopulation. These cells were 1400- to 1600-fold enriched in long-term functional ability compared to fresh marrow. This very high multilineage repopulating ability per cell was directly measured using a long-term functional assay in vivo. Importantly, the measured repopulating ability for AA4.1+/Linlow/Sca+ cells was about five-fold less than expected from the fraction of cells enriched and remained two- to three-fold less even after compensating for repopulating ability in discarded fractions. This illustrates that long-term functional abilities of enriched PHSC cannot be estimated from fractions enriched but should be quantitatively assayed.
为了描述造血细胞生物学特性,许多研究人员使用了富集原始造血干细胞(PHSC)的方案。在本研究中,我们使用竞争性再增殖试验,对来自第14天小鼠胎肝的PHSC富集和丢弃部分的长期再增殖能力(LTRA)进行了量化。我们使用抗原标志物AA4.1+、AA4.1+/Sca+和AA4.1+/Linlow/Sca+对胎儿细胞群体进行了分级分离。使用竞争性再增殖直接比较了这些群体中每个群体的分化和再增殖能力。将成年骨髓与来自具有遗传可区分标志物的同基因供体的胎儿细胞部分混合,并将混合物给予受辐照的受体。通过再增殖受体的具有供体标志物的髓系和淋巴细胞的比例来测量富集的供体细胞的分化和再增殖能力。发现LTRA主要存在于AA4.1+和AA4.1+/Sca+亚群中。对AA4.1+细胞进一步分级分离以获得AA4.1+/Linlow/Sca+部分,结果表明几乎所有的长期干细胞活性都存在于该亚群中。与新鲜骨髓相比,这些细胞的长期功能能力富集了1400至1600倍。使用体内长期功能试验直接测量了每个细胞这种非常高的多谱系再增殖能力。重要的是,测量的AA4.1+/Linlow/Sca+细胞的再增殖能力比根据富集细胞部分预期的能力低约五倍,即使在补偿了丢弃部分的再增殖能力后,仍低两至三倍。这表明富集的PHSC的长期功能能力不能从富集部分进行估计,而应该进行定量测定。